Reliance Global Group, Inc. — News

Transaction Expected to Generate Approximately $7.6 Million of Aggregate Incremental Cash After Retiring 100% of the Company's Term Debt

globenewswire.com - 2026-08-03 08:30:00

Reliance Global Group, Inc. (EZRA) Q2 2026 Earnings Call Transcript

seekingalpha.com - 2026-07-30 22:43:18

Proprietary AI Platform Enhances Insurance Operations and Positions Company for Long-Term Growth Company to Host Conference Call Today at 4:30 PM Eastern Time LAKEWOOD, N.J., July 30, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (Nasdaq: EZRA) (“we,” “us,” “our,” the “Company” or “Reliance”) today reported financial results for the second quarter ended June 30, 2026, while highlighting continued progress in the development and deployment of its proprietary artificial intelligence platform designed to enhance operational efficiency, automate complex workflows, and create new long-term growth opportunities.

globenewswire.com - 2026-07-30 16:25:00

Lakewood, NJ, July 28, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (NASDAQ: EZRA) (“Reliance” or the “Company”), announced today that it will host a conference call Thursday, July 30, 2026, at 4:30 PM Eastern Time to discuss financial results for the second quarter 2026 and provide a business update.

globenewswire.com - 2026-07-28 08:30:00

Reliance's proprietary AI agent brings secure environments, policy-enforced action controls, human-in-the-loop review, and audit-grade records to regulated industries, beginning with insurance back offices Reliance's proprietary AI agent brings secure environments, policy-enforced action controls, human-in-the-loop review, and audit-grade records to regulated industries, beginning with insurance back offices

globenewswire.com - 2026-07-14 08:30:00

Appointments of Zack Wilder as CTO, Judah Korman as COO, and Mordy Beyman as Executive Vice President to advance dual strategy: In-house development of planned AI-native insurance products and AI-powered agency acquisition roll-up Appointments of Zack Wilder as CTO, Judah Korman as COO, and Mordy Beyman as Executive Vice President to advance dual strategy: In-house development of planned AI-native insurance products and AI-powered agency acquisition roll-up

globenewswire.com - 2026-06-22 11:00:00

LAKEWOOD, NJ, June 03, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (Nasdaq: EZRA) (“we,” “us,” “our,” the “Company” or “Reliance”) today announced that it received formal notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC informing the Company that it has regained compliance with Nasdaq Listing Rule 5550(a)(2), the minimum bid price requirement for continued listing on Nasdaq.

globenewswire.com - 2026-06-03 08:30:00

Company Targets Multi-Billion-Dollar Cybersecurity Upgrade Cycle as Governments, Financial Institutions, AI Infrastructure Operators and Critical Networks Prepare for Emerging Quantum Threats to Legacy Encryption Company Targets Multi-Billion-Dollar Cybersecurity Upgrade Cycle as Governments, Financial Institutions, AI Infrastructure Operators and Critical Networks Prepare for Emerging Quantum Threats to Legacy Encryption

globenewswire.com - 2026-06-01 09:18:00

Israel Innovation Authority Approves Project Following Successful Real-World Construction Pilot Under EZRA International Group's Scale51 Initiative Israel Innovation Authority Approves Project Following Successful Real-World Construction Pilot Under EZRA International Group's Scale51 Initiative

globenewswire.com - 2026-05-18 09:27:00

LAKEWOOD, NJ, May 14, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (Nasdaq: EZRA) ("Reliance", "we" or the "Company") today announced that the Company's Board of Directors approved a 1-for-40 reverse stock split (the "Reverse Stock Split") of the Company's common stock (the "Common Stock") in order to regain compliance with the $1.

globenewswire.com - 2026-05-14 06:00:00

LAKEWOOD, NJ, May 14, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (Nasdaq: EZRA) (“Reliance”, “we” or the “Company”) today announced that the Company's Board of Directors approved a 1-for-40 reverse stock split (the “Reverse Stock Split”) of the Company's common stock (the “Common Stock”) in order to regain compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market (Rule 5550(a)(2)). The Company was not required to obtain shareholder approval to effectuate the Reverse Stock Split. The Company filed articles of amendment to the Company's articles of restatement to the articles of incorporation with the Florida Department of State, Division of Corporations which is expected to become effective as of 5:00 p.m. Eastern Time on May 15, 2026.  The Common Stock will begin trading on The Nasdaq Capital Market on a reverse split-adjusted basis at the start of trading on May 18, 2026, under the symbol “EZRA” and under a new CUSIP number, 75946W 504.

globenewswire.com - 2026-05-14 06:00:00

Reliance Global Group, Inc. (EZRA) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-05-08 01:41:16

Company Expands Ownership-Driven Investment Model While Maintaining Insurance and InsurTech Operating Foundation Company to Host Conference Call Today at 4:30 PM Eastern Time LAKEWOOD, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (Nasdaq: EZRA) (“we,” “us,” “our,” the “Company” or “Reliance”) today reported financial results for the three months ended March 31, 2026, and provided an update on the continued execution of its Scale51 strategy through targeted investments in technology and life sciences platforms.

globenewswire.com - 2026-05-07 16:08:00

Lakewood, NJ, May 06, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (NASDAQ: EZRA) (“Reliance” or the “Company”), announced today that it will host a conference call Thursday, May 7, 2026, at 4:30 PM Eastern Time to discuss financial results for the first quarter 2026 and provide a business update.

globenewswire.com - 2026-05-06 11:00:00

LifeSci Global Launches as Reliance's Life Sciences Platform, Partnering with Scott Korman and David Turner as Its Founding Operator-Partners to Build, Lead and Grow the Platform

globenewswire.com - 2026-05-05 09:25:00

Transaction Expands EZRA International Group's Biotech Division, LifeSci Global, Into Late-Stage Radiopharmaceutical Imaging Initial Neuroblastoma Opportunity of Approximately $250 Million, with Additional Potential Billion-Dollar Expansion Markets and Priority Review Voucher Upside LAKEWOOD, N. J. , May 04, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (Nasdaq: EZRA) ("we," "us," "our," the "Company" or "Reliance") today announced that LifeSci Global Group LLC ("LifeSci Global"), the biotech arm of EZRA International Group, has completed a strategic investment in Innervate Radiopharmaceuticals, a developer of positron emission tomography (PET) imaging and therapeutic radiopharmaceuticals focused initially on neuroblastoma and broader future applications in cardiovascular and neurodegenerative disease.

globenewswire.com - 2026-05-04 08:17:00

Transaction Expands EZRA International Group's Biotech Division, LifeSci Global, Into Late-Stage Radiopharmaceutical Imaging

globenewswire.com - 2026-05-04 08:17:00